FDA Inspection 1006241 — Adare Pharmaceuticals Srl
The FDA completed an inspection of Adare Pharmaceuticals Srl on Feb 24, 2017 in Pessano Con Bornago. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Feb 24, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Pessano Con Bornago (Italy)
Citations
| ID | CFR | Description |
|---|---|---|
| 3610 | 21 CFR 211.160(b)(3) | Drug product sample |